期刊文献+

S-三甲基-L-半胱氨酸对膀胱尿路上皮癌细胞Eg5基因表达和凋亡的影响

Effects of S-trimethyl-L-cysteine on Eg5 gene expression and apoptosis in bladder urothelial carcinoma cells
在线阅读 下载PDF
导出
摘要 目的:体外观察纺锤体驱动蛋白Eg5抑制剂S-三甲基-L-半胱氨酸(STLC)对人膀胱尿路上皮癌BIU-87细胞Eg5基因表达和凋亡的影响。方法:分别采用流式细胞术、四甲基偶氮唑盐微量酶反应(MTT)比色法、TUNEL染色法、逆转录-聚合酶链反应(RT-PCR)和Western Blotting法检测STLC对人膀胱癌BIU-87细胞的细胞周期、生长抑制率、凋亡指数、Eg5 mRNA及其蛋白相对表达水平的影响。结果:将STLC与BIU-87细胞共孵育,不同时间点收集细胞,可见随着STLC作用时间延长至16 h,细胞有丝分裂周期中G2/M期的BIU-87细胞明显增多(29.6%),且细胞发生凋亡的比例也有明显增加的趋势。统计分析显示,与0 h相比,STLC处理16 h时细胞凋亡比例升高,差异有统计学意义(P=0.020)。去除STLC后再培养,于不同时间点收集细胞,结果表明STLC去除后BIU-87细胞周期进程开始恢复,与去除1 h时G2/M期细胞比例(34.84%)相比,去除3 h后G2/M期细胞比例(24.9%)显著降低,差异有统计学意义(P=0.001);细胞凋亡比例差异也有统计学意义(P=0.049)。与对照组相比,STLC处理组细胞增殖抑制率和凋亡指数均显著升高,差异有统计学意义(P<0.001);与对照组相比,STLC处理组Eg5 mRNA和蛋白的表达水平均显著降低,差异有统计学意义(P<0.001)。结论:STLC可有效抑制Eg5基因表达并诱导人膀胱尿路上皮癌BIU-87细胞凋亡,为膀胱尿路上皮癌的药物治疗提供了实验依据和理论基础。 Objective:To observe the effect of S-trimethyl-L-cysteine(STLC),a spindle kinesin Eg5 inhibitor,on Eg5 gene expression and apoptosis in human bladder urothelial carcinoma BIU-87 cells in vitro.Methods:The cell cycle,growth inhibition rate,apoptosis index and Eg5 of human bladder cancer BIU-87 cells were detected by flow cytometry,MTT assay,TUNEL staining,reverse transcription-polymerase chain reaction(RT-PCR)and Western Blotting,respectively Effect of relative expression levels of mRNA and protein.Results:BIU-87 cells were coincubated with STLC,and cells were collected at different time points.As the treatment time of STLC extended to 16 h,the number of BIU-87 cells in G2/M phase of mitotic cycle increased significantly(29.6%),and the proportion of cells undergoing apoptosis also showed a significant increase trend.Statistical analysis showed that compared with 0 h,the proportion of apoptosis was increased at 16 h of STLC treatment,and the difference was statistically significant(P=0.020).Cells were collected at different time points after STLC removal.The results showed that the cycle progression of BIU-87 cells began to recover after STLC removal.Compared with the proportion of cells in G2/M phase(34.84%)at 1 h removal,the proportion of cells in G2/M phase(24.9%)at 3 h removal was significantly reduced.The difference was statistically significant(P=0.001).The proportion of apoptosis was also significantly different(P=0.049).Compared with the control group,the proliferation inhibition rate and apoptosis index of STLC treatment group were significantly increased(P<0.001).Compared with the control group,the expression levels of Eg5 mRNA and protein in the STLC treatment group were significantly decreased(P<0.001).Conclusion:STLC can effectively inhibit the expression of Eg5 gene and induce apoptos is of human bladder urothelial carcinoma BIU-87 cells,which provides experimental and theoretical basis for drug treatment of bladder urothelial carcinoma.
作者 曹正国 田超 钟苏权 周琳雄 陈桂柳 CAO Zhengguo;TIAN Chao;ZHONG Suquan;ZHOU Linxiong;CHEN Guiliu(Second Department of Urology,North Guangdong People’s Hospital,Shantou University Medical College,Shaoguan Guangdong 512026)
出处 《当代医药论丛》 2022年第21期10-14,共5页
基金 广东省自然科学基金资助项目(编号S2011010004230) 韶关市科技计划资助(编号2019sn004) 韶关市卫健局资助项目(编号Y20144)。
关键词 膀胱尿路上皮癌 细胞凋亡 Eg5基因 S-三甲基-L-半胱氨酸 Bladder urothelial carcinoma Apoptosis Eg5 genes S-trimeth yl-L-cysteine
作者简介 曹正国(1975-),男,汉族,博士,硕士生导师,主任医师,研究方向:泌尿系肿瘤的临床与基础研究,E-mail:19655975@qq.com。
  • 相关文献

参考文献2

二级参考文献22

  • 1SOLTANIAN S, MATIN MM. Cancer stem cells and cancer therapy [J]. Tumour Biol, 2011, 32(3): 425-440.
  • 2CHEN L, SHEN R, YE Y, et al. Precancerous stem cells have the potential for both benign and malignant differentiation[J].PLos One, 2007, 2(3) :e293.
  • 3SINGH SK, CLARKE ID, Terassakl M, et al. Identification of a cancer stem cell in human brain tumors [J]. Cancer Res, 2003, 63(18): 5821-5828.
  • 4CROKER AK, ALl.AN AL. Cancer stem cells: smplieations for the progression and treatment of metastatic disease [J]. J Cell Mol Med, 2008, 12(2): 374-390.
  • 5ZHOU BB, ZHANG H, DAMEL1N M, et al. Tumor-initiating ceils: chanllenges and opportunities for anticancer drug discovery [J]. Nat RevDrugDiscov, 2009, 8(10): 806-823.
  • 6FRIEL AM, SERGENT PA, PATN.A_UDE C, et al. Functional analyses of the cancer stem cell-like properties of human endome- trial tumor initiating cells [J]. Cell Cycle, 2008, 7 (2): 242-249.
  • 7HEMMATI HD, NAKANO I, LAZAREFF JA, et al. Cancer- ous stem cells can arise from pediatric brain tumors [J]. Proc Natl Acad Sci U S A, 2003, 100(25): 15178-15183.
  • 8LEE J, KOTLIAROVA S, KOTIIAVOV Y, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines [J]. Cancer Ceil, 2006, 9(5) : 391-403.
  • 9GUPTA PB, CHAFFER CL, WEINBERG RA. Cancer stem cells: mirage or reality? [J]. Nat Med, 2009, 15 (9): 1010-1012.
  • 10LEE JH, SCHUTTE D, WULF G, et al. Stem cell protein Pi-wil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway [Jl. Hum Mol Genet, 2006, 15(2): 201-211.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部